Covid 19 Research using Clinical Trials (Home Page)
BiosensorWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (3)
|
Name (Synonyms) |
Correlation |
drug688 | Recombinant novel coronavirus vaccine (Adenovirus type 5 vector) Wiki | 1.00 |
drug151 | COVID-19 RT-PCR Wiki | 0.58 |
drug616 | Placebo Wiki | 0.10 |
Correlated MeSH Terms (1)
|
Name (Synonyms) |
Correlation |
D000257 | Adenoviridae Infections NIH | 0.71 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The objective of study is to estimate the sensitivity and specificity of the COR-DIAL based
on nasopharyngeal samples taken at the patient's admission in relation to the final diagnosis
of COVID-19 made by the medical team.
NCT04367142 Sars-CoV2 Diagnostic Test: COVID-19 RT-PCR Diagnostic Test: Biosensor
Primary Outcomes
Measure: Sensitivity and specificity of the COR-DIAL based on nasopharyngeal swabs taken on admission of the patient compared to the final diagnosis of COVID-19 made by the medical team Time: Baseline (at admission)
Secondary Outcomes
Measure: Cohen's Kappa Coefficient for concordance for the diagnosis of CoV-2-SARS between PCR and COR-DIAL based on nasopharyngeal swabs taken on patient admission Time: Baseline (at admission)
No related HPO nodes (Using clinical trials)